No article text was recorded for this version.
dual immune checkpoint inhibition
Version 2 of 223 papers34 conceptsfrozen 2026-10-04
Papers in this version
- Blog: 435 ES038, a novel NKCE molecule targeting LILRB4 in AML via dual engagement of NKG2A and NKG2C
- Blog: 1211 Dual targeting of innate and adaptive immune checkpoints with a PD-L1/SIRPα bispecific macrophage engager to promote anti-tumor activity
- Blog: HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models
- Blog: 1364 Discovery of NXA01, a novel CD24 antibody with tumor selectivity and potent anti-tumor activity
- Blog: The Combination of Anti-CD47 Antibody with CTLA4 Blockade Enhances Anti-Tumor Immunity in Non-Small Cell Lung Cancer via Normalization of Tumor Vasculature and Reprogramming of the Immune Microenvironment
- Blog: The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study
- Blog: Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy
- Blog: 793 Treatment of anti-SIRPα in combination with anti-TAA exerts superior anti-tumor activity
- Blog: Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines
- Blog: Advances in PD-1/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives
- Blog: Early B cell changes predict autoimmunity following combination immune checkpoint blockade
- Blog: SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression <i>via</i> inhibiting ROS and caspase-3 in mice
- Blog: Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma
- Blog: 9 A novel humanized mouse model for assessing anti-tumor therapy with anti-human PD-1 and human IL12 bispecific antibody
- Blog: Preclinical pharmacology characterization of HX009, a novel PD1 x CD47 Bi-specific antibody
- Blog: Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
- Blog: The co-stimulation of anti-CD28 and IL-2 enhances the sensitivity of ELISPOT assays for detection of neoantigen-specific T cells in PBMC
- Blog: Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model
- Blog: Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation
- Blog: Absence of central tolerance in Aire-deficient mice synergizes with immune-checkpoint inhibition to enhance antitumor responses
- Blog: The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer
- Blog: Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives
- Blog: Finding test-and-treatment procedures using parallel computation. Technical paper
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_dual_immune_checkpoint_inhibition_c9193b46,
title = {dual immune checkpoint inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/dual-immune-checkpoint-inhibition/rdr_c9193b4629d7465581e2d32eaeea3dbc},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 2, frozen text):
@misc{lacuna_dual_immune_checkpoint_inhibition_c9193b46_v2,
title = {dual immune checkpoint inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/dual-immune-checkpoint-inhibition/rdr_c9193b4629d7465581e2d32eaeea3dbc/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-20},
}